Join BOPA

Essential resources, easily available.

Our e-learning modules, resources and forums provide oncology pharmacy staff with the tools required to stay abreast of the latest developments to improve patient care.

eLearning

  • Field-specific online modules
  • Supporting certification that can be used to support CPD
  • Keep up to date within the field of oncology pharmacy
  • Stop and continue the course at a time that suits you
Explore eLearning

Your community

  • Innovation through collaboration
  • Communicate with other members of the oncology pharmacy network
  • Share documents and links
  • Submit posts quickly and easily on our interactive forums
Explore community

Resources

  • Access to BOPA publications and position statements
  • Links for further reading and information
  • Checked and verified documents ensures material is current
  • Quick downloads
Explore resources

Latest news

Further news
By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article
Further news